期刊文献+

2型糖尿病足部自主神经病变与C肽水平的相关性研究 被引量:8

The Correlation Analysis between C-Peptide Level and Autonomic Neuropathy in Type 2 Diabetic Patients
下载PDF
导出
摘要 目的探讨C肽水平与2型糖尿病(T2DM)足部自主神经病变的关系。方法检测124例T2DM患者的空腹血糖(FBG)、餐后2 h血糖(2 h-PG)、空腹C肽(FC-P),利用欧米诺诊断膏贴测定足部神经泌汗功能,根据患者足部神经泌汗功能检查结果,分为糖尿病自主神经病变(DAN)组及非自主神经病变(NDAN)组,比较2组性别、年龄、体质指数、血压、FBG、2 h-PG、FC-P水平。将欧米诺诊断膏贴完全变色时间与上述指标进行Pearson相关分析。结果 2组患者性别、年龄、FBG、2 h-PG比较差异无统计学意义(P>0.05),DAN组患者FC-P水平为(1.07±0.75)nmol/L,低于NDAN组的(1.43±1.00)nmol/L(P<0.05)。糖尿病足部欧米诺诊断膏贴变色时间与C肽呈负相关。结论T2DM患者足部自主神经功能与C肽密切相关,推测C肽可能对足部自主神经具有保护性作用。 Objective To discuss the correlation between C-peptide level and autonomic neuropathy in diabetic foot in patients with type 2 diabetes mellitus (T2DM). Methods The levels of fasting blood glucose (FBG), 2 h postprandial blood glucose (2 h-PG) and fasting C-peptide (FC-P) were detected in 124 T2DM patients. The Neuropad was used to test functions of sudomotor nerves in foot. Patients were divided into two groups:diabetic autonomic neuropathy (DAN) group and non-autonomic neuropathy group (NDAN) according to the results of functions of sudomotor nerves in foot. Values of gender, age, body mass index (BMI), blood pressure, FBG, 2 h-PG and FC-P were compared between the two groups. The Pearson correlation analysis was carried out between the indexes mentioned above and the time for completing color change of Neuro-pad. Results There were no significant differences in gender, age, FBG and 2 h-PG between two groups (P〉0.05). The FC-P level was (1.07 ± 0.75)nmol/L in DAN group, which was significantly lower than that in NDAN group (1.43 ± 1.00) nmol/L (P 〉 0.05). The time for completing color change of Neuropad was negatively correlated with C-peptide. Conclu-sion The autonomic nerve functions in diabetic foot is closely related with C-peptide. It is inferred that C-peptide may have protective effect on autonomic nerves in diabetic foot.
出处 《天津医药》 CAS 北大核心 2014年第7期677-679,共3页 Tianjin Medical Journal
基金 广西壮族自治区卫生厅课题(Z2008028)
关键词 C肽 糖尿病 2型 糖尿病神经病变 欧米诺汗迹 C-peptide diabetes mellitus, type 2 diabetic neuropathies neuropad
  • 相关文献

参考文献9

  • 1Otto-Buczkowska E,Kazibutowska Z,Sofiyk J,et al.Neuropathy and type 1 diabetes mouitus[J].Pediair Endocrinol Diabetes Metab, 2008,14(2): 109-116.
  • 2谢新荣,赵弋于,马春苏,欧玉明.糖尿病足部汗腺分泌功能与周围神经病变及周围血管病变的关系[J].中国老年学杂志,2012,32(22):4859-4861. 被引量:10
  • 3Papanas N,Giassakis G,Papatheodorou K,et al. Use of the new indi-cator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients[J].Exp Clin Endocrinol Dia- betes, 2007,115 ( 1): 58-61.
  • 4Papanas N, Boulton AJ, Malik RA,et al.A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy [J].Dia- bet Med, 2013,30(5):525-534. doi: 10.1111/dme. 12000.
  • 5Tentolouris N,Vonlgari C,Liatis S,et al.Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ul- ceration in diabetes[J].Diabetes Care, 2010, 33(5): 1112-1114. doi: 10.2337/dc09-2027.
  • 6张东铭,王崇贤,张苏河.2型糖尿病周围神经病变与C肽水平的相关性研究[J].中国实用神经疾病杂志,2011,14(3):12-14. 被引量:11
  • 7赵菲菲,安超,王强,姜璐,谭雯,张磊,董砚虎.2型糖尿病周围神经病变与C肽水平的相关性研究[J].中国医药科学,2013,3(4):20-21. 被引量:6
  • 8Ekberg K,Brismar T,Johansson B,et al.C-Peptide replacement thera- py and sensory nerve function in type 1 diabetic neuropathy [J].Dia- betes Care, 2007,30(1):71-76.
  • 9Bo S,Gentile L, Castiglione A,et al.C-peptide and the risk for inci- dent complications and mortality in type 2 diabetic patients: a retro- spective cohort study after a 14-year follow-up[J].Eur J Endocrinol, 2012,167(2):173-180.doi: 10.1530/EJE-12-0085.

二级参考文献17

  • 1李菁爽,詹晓蓉,阴慧清.C肽对糖尿病大鼠坐骨神经结构和功能的影响[J].现代生物医学进展,2006,6(11):9-10. 被引量:4
  • 2Maxim Dobretsov,Dmitry Romanovsky,Joseph R Stimers.Early diabetic neuropathy:Triggers and mechanisms[J].World Journal of Gastroenterology,2007,13(2):175-191. 被引量:55
  • 3徐咏平,邓康平,张木勋.糖尿病周围血管病变对周围神经病变的影响[J].中国康复,2007,22(2):85-87. 被引量:12
  • 4John Wahren.C-peptide new findings and therapeutic implicationsin diabetes[J].Clinical Physoology and Functional Imaging,2004,24(4):180-189.
  • 5Sima AA,Zhang W,Sugimoto K,et al.C-peptide prevents and improves chronic type 1 diabetic polyneuropathy in the BB/Wor rat[J].Diabetologia,2001,44(7):889-897.
  • 6Ekberg K,Brismar T,Johansson BL,et al.C-Peptide replacement therapy and sensory nerve function in type1 diabetic neuropathy[J].Diabetes Care,2007,30(1):71-76.
  • 7Johansson BL,Borg C,FernvistForbes E,et al.C-peptide improve autonomic nerve function in IDDM pation[J].Diabetologia,1996,39:687-695.
  • 8Cameron N E, Cotter M A.Pro-inflammatory mechanisms in diabetic neuropathy:focus on the nuclear factor kappa B pathway[J].Curr Drug Targets, 2008,9 : 60-67.
  • 9Karin E, Tom B, Bo-Lennart J, et aL.C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy[J].Diabetes Care,2007, 30: 71-76.
  • 10Morkrid K, Ali L, Hussain A.Risk factors and prevalence of diabetic peripheral neuropathy:A study of type 2 diabetic outpatients in Bangladesh[J].Int J Diabetes Dev Ctries, 2010, 30 ( 1 ) : 11-17.

共引文献24

同被引文献55

  • 1Venturini M,Fiorina P,Maffi P,et al.Early increase of retinal arterial and venous blood flow velocities at color Doppler imaging in brittle type 1 diabetes after islet transplant alone[J].Transplantation,2006,81(9):1274-1277.
  • 2Turlin B,Mendler MH,Moirand R,et al.Histologic features of the liver in insulin resistance-associated ironoverload.A study of 139 patients[J].Am J Clin Pathol,2001,116(2):263-270.
  • 3Kamiya H,Zhang W,Ekberg K,et al.C-Peptide reverses nociceptive neuropathy in type 1 diabetes[J].Diabetes,2006,55(12):3581-3587.
  • 4Vedhara K, Dawe K, Wetberell MA, et al. Illness beliefs predict self-care behaviours in patients with diabetic foot ulcers: A prospective study [ J ]. Diabetes Res Clin Pract,2014,106 ( 1 ) : 67- 72.
  • 5Robert J, Commons, Claire H. Robinson, David Gawler, et al. High burden of diabetic foot infections in the top end of Australia: An emerging health crisis( DEFINE study) [ J]. Diabetes Research and Clinical Practice,2015,1 10 (2) : 147-157.
  • 6Crozier L. Diabetic foot-related problems: improving outcomes in the dialysis population using a foot assessment screening tri- algorithm (FAST) [J]. Nephrol Nuns J,2014,41 (4) :381-390.
  • 7Mohammad Zubair, Jamal Ahmad. Plasma Heat Shock Proteins (HSPs) 70 and 47 levels in diabetic foot and its possible correlation with clinical variables in a North Indian Tertiary care hospital[ J]. Diabetes & Metabolic Syndrome: Clinical Research & Reviews,2015,9(4) :237-243.
  • 8Gardner SE, Haleem A, Jao YL, et al. Cultures of diabetic foot deers without clinical signs of infection do not predict outcomes [ J ]. Diabetes Care,2014,37 (10) :2693-2701.
  • 9焦剑,李颖.C肽与糖尿病视网膜病变[J].国际眼科杂志,2008,8(7):1441-1443. 被引量:5
  • 10金兴权,王丽萍,张斌,林洁,陈晓萍,顾春江.C肽变化与糖尿病周围神经病变的关系[J].山东医药,2009,49(37):16-18. 被引量:15

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部